Showing results (401-410 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot StudyAvi Leader, Anat Gafter-Gvili, Noam Benyamini, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World ExperienceMuhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 3, 2022
Clinical Characteristics and Survival Outcomes of Primary Effusion Lymphoma: A National Cancer Database StudyFiras Baidoun, Muhamad Alhaj Moustafa, Han W Tun, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2022
Impact of Insurance on Overall Survival in Acute Lymphoblastic Leukemia: A SEER Database StudyUtsav Joshi, Shital Khanal, Uttam Bhetuwal, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 5, 2022
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group DatabaseHira Mian, Donna Reece, Esther Masih-Khan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 30, 2022
Incidence and Prognostic Significance of High-Risk Cytogenetically Abnormalities in Multiple Myeloma Patients in ColombiaJuan Felipe Combariza, Rocío Ordúz, Claudia Agudelo, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 6, 2018
Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia RelapseKiyomi Mashima, Iekuni Oh, Takashi Ikeda, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 23, 2018
Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-analysisWeerapat Owattanapanich, Natthida Owattanapanich, Smith Kungwankiattichai, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 29, 2018
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin LymphomaRachel J David, Andrea Baran, Kah Poh Loh, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 6, 2018
Society of Hematologic Oncology State of the Art Update and Next Questions: Multiple MyelomaJoshua Richter, Sundar Jagannath
Pageof 251